BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 7304626)

  • 1. Technical problems associated with the production of technetium Tc 99m tin(II) pyrophosphate kits.
    Kowalsky RJ; Dalton DR
    Am J Hosp Pharm; 1981 Nov; 38(11):1722-6. PubMed ID: 7304626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: Stability of stannous ion in stannous pyrophosphate kits.
    Kowalsky RJ; Chilton HM
    J Nucl Med; 1983 Nov; 24(11):1080-1. PubMed ID: 6631529
    [No Abstract]   [Full Text] [Related]  

  • 3. Technetium-99m labeling of polymorphonuclear leukocytes: preparation with two different stannous agents.
    Kelbaek H; Fogh J
    J Nucl Med; 1985 Jan; 26(1):68-71. PubMed ID: 3965654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of technetium-99m pyrophosphate and technetium-99m methylene diphosphonate with variable amounts of stannous chloride in the detection of acute myocardial infarction.
    Huckell VF; Lyster DM; Morrison RT; Cooper JA
    Clin Nucl Med; 1985 Jul; 10(7):455-62. PubMed ID: 4028596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro technetium-99m red blood cell labeling using commercial stannous pyrophosphate.
    Zimmer AM
    Am J Hosp Pharm; 1977 Mar; 34(3):264-7. PubMed ID: 857670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium-99m radiopharmaceutical preparation by surface adsorbed stannous ions.
    Salehi N; Lichtenstein M; Pojer PM
    J Nucl Med; 1987 Jun; 28(6):1041-6. PubMed ID: 3675734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiochemical purity and stability of Tc-99m-pyrophosphate].
    Vucina J
    Med Pregl; 2000; 53(9-10):502-5. PubMed ID: 11320732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stoichiometric Tc-99m RBC labeling using stable kit solutions of stannous chloride and EDTA: concise communication.
    Mock BH; Wellman HN
    J Nucl Med; 1984 Aug; 25(8):881-6. PubMed ID: 6431061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of source and age of sodium pertechnetate Tc 99m on radiochemical purity of technetium Tc 99m exametazime.
    Millar AM
    Am J Hosp Pharm; 1993 Jan; 50(1):103-6. PubMed ID: 8381258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the labeling of streptokinase with 99mTc for use as a radiopharmaceutical in the detection of deep-vein thrombosis: concise communication.
    Duffy MJ; Duffy GJ
    J Nucl Med; 1977 May; 18(5):483-5. PubMed ID: 16092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decomposition of Tc-99m pyrophosphate by peroxides in pertechnetate used in preparation.
    Der M; Ballinger JR; Bowen BM
    J Nucl Med; 1981 Jul; 22(7):645-6. PubMed ID: 6265608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo distribution of Tc-99m(Sn)pyridoxylideneisoleucine: effects of storage and labeling conditions. Concise communication.
    Kato M
    J Nucl Med; 1979 Nov; 20(11):1189-93. PubMed ID: 536780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deterioration of stannous ion in radiopharmaceutical kits during storage.
    McBride MH; Shaw SM; Kessler WV
    Am J Hosp Pharm; 1979 Oct; 36(10):1370-2. PubMed ID: 507080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo labeling of red blood cells with Tc-99m with stannous pyridoxylideneaminates.
    Kato M
    J Nucl Med; 1979 Oct; 20(10):1071-4. PubMed ID: 536758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An improved (99m)Tc-aprotinin kit formulation: quality control analysis of radiotracer stability and cold kit shelf life.
    Smyth DR; Tsopelas C
    Nucl Med Biol; 2005 Nov; 32(8):885-9. PubMed ID: 16253814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic aspects of the interaction of 99mTc in association with stannous pyrophosphate with damaged red blood cells.
    Billinghurst MW; Waddell TL
    Int J Appl Radiat Isot; 1983 Mar; 34(3):607-12. PubMed ID: 6303965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Sn(II) ion concentration and heparin on technetium-99m red blood cell labeling.
    Rao SA; Knobel J; Collier BD; Isitman AT
    J Nucl Med; 1986 Jul; 27(7):1202-6. PubMed ID: 3014088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of technetium-99m stannous pyrophosphate in contused myocardium.
    Downey J; Chagrasulis R; Fore D; Parmley LF
    J Nucl Med; 1977 Dec; 18(12):1171-5. PubMed ID: 606739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting the labeling efficiency and stability of technetium-99m-labeled glucoheptonate.
    Zbrzeznj DJ; Khan RA
    Am J Hosp Pharm; 1981 Oct; 38(10):1499-502. PubMed ID: 7294045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and biological distribution of technetium diphosphonate radiotracers synthesized without stannous ion.
    Deutsch E; Libson K; Becker CB; Francis MD; Tofe AJ; Ferguson DL; McCreary LD
    J Nucl Med; 1980 Sep; 21(9):859-66. PubMed ID: 6774066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.